Sign in

Joseph Chee

Executive Chairman at Solana
Executive
Board

About Joseph Chee

Joseph Chee is Executive Chairman of the Board at Solana Company (f/k/a Helius Medical Technologies, Inc.) since September 18, 2025; the Board has determined he is not independent under Nasdaq rules and he serves as non‑independent Chair separate from the CEO role . On October 30, 2025, a subsidiary (Solana Company HK) entered into an Employment Agreement with Chee that provides executive compensation (base salary, bonus) in addition to his Executive Chairman Agreement . He holds advanced degrees including a Doctorate in applied finance (University of Geneva), an EMBA (Tsinghua), an MBA (NYU), and a BS in mechanical engineering (Stevens Institute of Technology) . As of October 1, 2025, he beneficially owned 6,830,401 shares (16.95% of shares outstanding), indicating significant alignment with stockholders .

Board service history and governance implications:

  • Board service: Executive Chairman since Sep 2025; term to the 2026 annual meeting; not independent .
  • Committee roles: The three standing committees (Audit, Compensation, Nominating & Corporate Governance) are chaired by independent directors; Chee is not listed as a committee member .
  • Dual-role implications: Non‑independent Chair with separate CEO structure; Board cites this separation as enhancing oversight; however, Chair non‑independence elevates governance risk and necessitates robust independent committees and oversight .

Past Roles

OrganizationRoleYearsStrategic Impact
UBS AGHead of Investment Banking and Head of Global Capital Markets, Asia2000–2017Led capital markets and IB across Asia; deep capital formation expertise relevant to financing strategy
Summer Capital LimitedFounder & ChairmanAug 2017–presentEarly-growth investor in fintech, blockchain, consumer tech, healthcare; informs digital asset strategy and capital allocation

External Roles

OrganizationRoleYearsStrategic Impact
AMINA Bank AG (FINMA-regulated crypto bank)Vice ChairmanApr 2020–presentBridges TradFi and digital assets; domain expertise for company’s digital asset treasury initiative
Summer Healthcare Fund, L.P.FounderFeb 2021–presentHealthcare/biotech investing; network for partnerships/pipeline
Summer Everest Ecosystem Fund, L.P.FounderSep 2023–presentBlockchain ecosystem and fintech focus; potential strategic synergies

Fixed Compensation

ComponentAmount/TermsEffective Date(s)Notes
Base Salary$525,000 per year Oct 30, 2025Employment Agreement with Solana Company (Hong Kong) Limited; annually reviewed
Sign-on Cash Bonus$61,250 Oct 30, 2025In consideration of work from Sep 18, 2025 to Oct 30, 2025

Non‑employee director compensation policy (cash retainers, committee fees, equity retainer) applies to non‑employee directors; as Executive Chairman and executive, Chee’s compensation is governed by his agreements rather than the standard non‑employee director schedule .

Performance Compensation

Incentive TypeTarget/GrantMetric(s)Actual/PayoutVesting/Conditions
Annual Cash BonusTarget of 100% of base salary Discretionary (no specific metrics disclosed) Not disclosedDetermined annually; Employment Agreement
RSU Equity Award (Executive Chairman Agreement)RSUs equal to 1% of Cash Shares + Pre‑Funded Warrant Shares issued in the Offerings, plus 0.5% of the shares underlying Stapled Warrants; calculated at 1,109,118 RSUs Service related to implementing digital asset treasury Not disclosedSubject to stockholder approval of increase in 2022 EIP shares; RSUs subject only to the same restrictions as pre‑funded/stapled warrants, if applicable
Additional RSU Award (post‑exercise)Additional RSUs equal to 0.5% of Cash Stapled Warrants exercised (within 10 business days of exercise) Triggered by investor cash exercises of Stapled WarrantsNot disclosedSame plan approval condition; restrictions mirror underlying instruments where applicable

The Compensation Committee administers the company’s clawback policy (Policy for the Recovery of Erroneously Awarded Compensation) and oversees compensation risk; no specific Chee KPI weightings were disclosed .

Equity Ownership & Alignment

MeasureDetail
Beneficial Ownership6,830,401 shares; 16.95% of class as of Oct 1, 2025
Shares Outstanding (reference)40,299,220 as of Oct 1, 2025
Ownership BreakdownTable methodology attributes beneficial ownership to shares and derivatives exercisable/vestable within 60 days; specific Chee footnote breakdown not provided in excerpts
Hedging/PledgingInsider Trading Policy prohibits hedging/monetization transactions; excerpts reviewed do not explicitly state pledging prohibitions
Stock Ownership GuidelinesNot disclosed in excerpts for executives/directors (no specific multiples or compliance status found)
Potential Dilution/Related PartySummer Wisdom Holdings Limited (“Summer”), controlled by Chee, received Strategic Advisor Warrants: Base 2,218,236 warrants (3% of Cash+Pre‑Funded Warrant Shares) and eligible for additional Performance Warrants tied to Stapled Warrant exercises, with exercise price $0.001, term 5 years, cashless exercise, share‑settled; exercisable only upon stockholder approval; unvested terminate at expiry

Employment Terms

AgreementTerm/ScopeEconomicsTermination/COCOther Terms
Executive Chairman Agreement (Sep 18, 2025)One‑year term from Effective Date; Board member until next annual meeting; duties include implementing digital asset treasury Equity RSUs as specified above; expense reimbursement; D&O indemnification Upon termination, compensation/expenses through termination; no severance specified in excerpt May engage in other activities if no conflict; non‑competition with Company without approval; access to books/records
Employment Agreement (Oct 30, 2025) with Solana Company HKExecutive employment $525,000 base; $61,250 sign‑on; target annual bonus 100% of base; additional incentives per separate grant letter Severance/COC terms not disclosed in the 8‑K summary excerpt Standard indemnification agreement also referenced at director appointment; amended and restated indemnification agreements in Sep 2025 for directors and officers

Board Governance Summary

  • Structure and Independence: Chee serves as non‑independent Chair; board cites separation of Chair and CEO as current leadership structure .
  • Committees (2024–2025): Audit (Chair: Paul Buckman; all members independent; 5 meetings in 2024), Compensation (Chair: Edward M. Straw; all independent; 1 meeting in 2024), Nominating & Corporate Governance (Chair: Sherrie Perkins) .
  • Attendance: The board met four times in 2024; each then‑serving director attended ≥75% of meetings (Chee was not yet a director in 2024) .

Related Party Transactions (Key)

  • Strategic Advisor Agreement (Sep 15, 2025): Company engaged Pantera and Summer (controlled by Chee) as strategic advisors on crypto technology; Summer received Strategic Advisor Warrants (Base and Performance) at $0.001 strike, five‑year term, cashless, share‑settled, exercisable only upon stockholder approval under Nasdaq Rule 5635(a). Failure to obtain approval renders these warrants non‑exercisable .
  • Executive Chairman Agreement (Sep 18, 2025): RSU awards to Chee sized as a percentage of securities issued in Offerings and future Cash Stapled Warrant exercises; subject to stockholder approval of share increase under the 2022 EIP .

Risk Indicators & Red Flags

  • Non‑independent Chair: Concentration of influence at board level; mitigated by independent committee leadership .
  • Related Party Equity Economics: Summer (controlled by Chee) granted deeply in‑the‑money ($0.001) warrants contingent on stockholder approval; structure could create perceived conflicts and dilution risk if approved .
  • Compensation Metric Opacity: Employment Agreement provides a 100% target bonus but does not disclose specific performance metrics, reducing pay‑for‑performance transparency .
  • Governance Controls: Company maintains an insider trading policy with hedging prohibitions and pre‑clearance/blackouts, and a clawback policy administered by the Compensation Committee .

Investment Implications

  • Alignment and Control: Chee’s 16.95% beneficial stake signals strong alignment and potential influence over strategic direction and capital allocation .
  • Dilution/Approval Watch: Shareholder votes on (i) plan share increases enabling Chee’s RSU grants and (ii) exercisability of Strategic Advisor Warrants are key catalysts; approval would unlock meaningful incremental equity to Chee/Summer, potentially impacting float and future selling pressure dynamics .
  • Execution Focus: His mandate explicitly includes implementing a digital asset treasury; his AMINA/Summer background suggests capability, but execution entails regulatory/market risks; compensation tied to Offerings‑based instruments and Stapled Warrant activity partly shifts incentives toward financing outcomes over operating KPIs unless further metrics are adopted .
  • Governance Monitoring: Non‑independent Chair structure elevates the importance of robust independent committees; investors should monitor committee oversight, related‑party transaction approvals, and any future changes to Chee’s employment or equity terms .

Note: Information reflects disclosures in the company’s 8‑Ks (Sep 18, 2025; Nov 5, 2025), PRE 14A (Oct 2, 2025), and DEF 14A (Oct 14, 2025). Specific severance/COC economics, pledging policy, and detailed KPI weightings were not disclosed in the excerpts reviewed.